| abstract |
The sustained release anti-abuse dosage form includes grind-resistant release control particles that provide anti-abuse properties to the dosage form. The shatter resistant controlled release particles comprise a plastic / elastic polymer and at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof and are prepared by a hot melt extrusion process. [Selection] Figure 1 |